Navigation Links
USC biomedical team to participate in $6 million low vision project
Date:10/5/2007

An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.

The USC team, led by Norberto Grzywacz, professor of biomedical engineering in the Viterbi School and director of the USC Center for Vision Science and Technology, will join other researchers from Harvard Medical School and the University of Houston School of Optometry to address low vision problems caused by neural pathologies, such as macular degeneration and other diseases affecting the retina. Many of these vision problems are prevalent in older adults and cannot be fully corrected with ordinary lenses, medical treatment or surgery.

"Aging, injuries and diseases can all cause low vision, but the leading causes among older adults and the elderly are impairments such as age-related macular degeneration (AMD)," said Grzywacz, principal investigator on the five-year project, who also directs the USC Neuroscience Graduate Program. Our dream is to build devices like intelligent glasses or intelligent television displays that can improve these peoples lives.

AMD is a condition that usually develops in older adults and the elderly, and gradually destroys the central vision of the eye and an individuals ability to see fine detail. AMD patients quite often lose their ability to read, recognize faces and drive.

With an aging population, the incidence of AMD is on the rise. According to Grzywacz, approximately 3.5 percent of people in industrialized countries over the age of 75 have AMD.

That percentage rises to a staggering 18.5 percent for people over 85 years old, he said. AMD is also responsible for about 50 percent of all cases of registered blindness in indust
'/>"/>

Contact: Diane Ainsworth
dainswor@usce.edu
213-821-5808
University of Southern California
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Automatic extraction of gene/protein biological functions from biomedical text
2. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
3. Scientists create digital bacteria to forge advances in biomedical research
4. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
5. Yale participates in global human genome initiative
6. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
7. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
8. Six million Africans face famine because of locusts, drought
9. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
10. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
11. $5.1 billion would save 6 million children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... Singapore laboratory that deciphered the DNA code...nd elephant shark, has joined The Genome 10K Proje... repository of DNA sequences on 10,000 species of ...ale that currently can not be achieved. , Partic...paper published in the Nov. 5, 2009 issue of the ...
(Date:11/4/2009)... MADISON, N.J., Oct. 20 ...world,s leading provider of diagnostic testing, in...rd quarter ended September 30, 2009, income from c...2 per diluted share, from $160 million, or $0.81 p...n 2008, third quarter results were reduced by a $0...
(Date:11/4/2009)... RIDGE, N.Y., Oct. 21 What,s the c...venting accidental death resulting from prescripti... with good intentions, however, may be unaware tha...ing their teens from the ticking timebomb of presc...eader in premium-quality medical supplies, has for...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 1Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 1Palomar Medical Reports Financial Results for Second Quarter 2009 53208 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 3Palomar Medical Reports Financial Results for Second Quarter 2009 53208 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 5Palomar Medical Reports Financial Results for Second Quarter 2009 53208 6Palomar Medical Reports Financial Results for Second Quarter 2009 53208 7Palomar Medical Reports Financial Results for Second Quarter 2009 53208 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 1CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 3CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 4CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 5CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 6CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 7CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 9CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 10CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 11CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 12CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 13CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 14CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 15
...rchers have decoded the genetic makeup of the para...ommon sexually transmitted infections (STIs), reve...ecome increasingly drug resistant and suggesting p...nd a potential vaccine strategy. The genome sequen...Allergy and Infectious Diseases (NIAID), part of t...
... there is no cure for lingering viral infections s... University suggests it may be possible to deactiv...genetic switch. , Princeton scientists Leor Weinb...nate the processes by which human immunodeficiency...mant phases in their hosts. The researchers have d...
...ional workplace ban on smoking in Ireland resulted...bs, an 80 percent decrease in airborne carcinogens...respiratory health of bar workers, according to a ...n the second issue for April 2007 of the American ... published by the American Thoracic Society. , ...
Other Biology News:Scientists sequence genome of parasite responsible for common sexually transmitted infection 2Scientists sequence genome of parasite responsible for common sexually transmitted infection 3Scientists find potential 'off-switch' for HIV virus 2Scientists find potential 'off-switch' for HIV virus 3Scientists find potential 'off-switch' for HIV virus 4Smoking ban dramatically reduces air pollution in Irish pubs 2Smoking ban dramatically reduces air pollution in Irish pubs 3
(Date:11/6/2009)...wswire/ -- Myriant Technologies LLC ("Myriant"), a...r of renewable bio-chemicals, Uhde Corporation of...e GmbH, one of the world,s leading engineering con...or the engineering, procurement & construction...based on renewable feedstocks. The execution of t...
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...Sales Grow to $10.5 Million in 2007; MOXATAG, Comp...r-end; Process to Explore Strategic ... March 4 MiddleBrook,Pharmaceuticals, Inc. (Nasda...veloping and commercializing novel anti-infective ...l results for the quarter and fiscal year,ended De...
...h 4 SGX Pharmaceuticals,(Nasdaq: SGXP ) will ann...,full year 2007 on Wednesday, March 12, 2008. The ... call and webcast at 8:00 a.m. Pacific Time.,Mike ...odd Myers, Chief,Financial Officer, will host the ...usiness highlights., Interested participants and ...
... teams led by Dr. Michael Verkhovsky and Prof. Mrt...e University of Helsinki have for the first time s...x I in real time. In the future, this work might, ...of the maternally inherited so-called mitochondria... , This achievement required developing and build...
Other Biology Technology:MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 2MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 4MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 5MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 6MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 7MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 8MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 9MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 10MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 11MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 12MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 13MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 14MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 15SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results 2Biological electron transfer captured in real time 2
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: